Valproic acid for the treatment of pediatric malignant glioma.
about
The metabolic advantage of tumor cellsHistone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I studyAnti-tumor mechanisms of valproate: a novel role for an old drug.The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated IrradiationHistone deacetylase inhibitors: a review of their clinical status as antineoplastic agents.Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challengesValproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell linesEpilepsy, anti-epileptic medication use and risk of cancer.Effect of valproic acid on the outcome of glioblastoma multiforme.Valproic acid induces differentiation of a supratentorial primitive neuroectodermal tumor.Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats.Preliminary experience with personalized and targeted therapy for pediatric brain tumors.Potential role for valproate in the treatment of high--risk brain tumors of childhood-results from a retrospective observational cohort study.
P2860
Q21245765-45B4E873-30D5-4262-A1F3-998CC2D59155Q24810933-2E80906C-A156-47CF-874E-7B21952137C7Q34147644-8928D0B4-D09B-428D-848E-64703A0BF383Q35160462-66309B8C-5FB7-4C72-91E2-37AD1405E695Q35848726-5C0D8F4D-EDAD-422B-948D-2726BE469086Q35862318-2AF64569-2F8E-4A92-8F8A-68BC7E7D30EDQ36321399-C917769B-4D55-4B89-9E24-9BC7024763F7Q36524716-CAB8F9E1-0B7A-44BE-B294-E2546E6F3A8AQ37716414-14A56D1D-3929-414C-B4F7-D1B43679AD41Q39649184-B8092321-DF4C-4B97-81A0-3300A925DE8FQ44014855-28E4DDDB-2A21-4C8A-9DF3-B6E7652437F1Q45231801-76568DCA-2379-47AA-A1C5-78A905C0C927Q45288673-E1ABBC2C-0ABD-47CC-8C4C-B49598FB2D60Q46700667-231E14A8-BAF4-4DE8-B855-CB96A4BE6D93Q48785864-7867E0A3-FBEB-4431-B4A3-69CF19BB2F73Q49135107-7AAF2266-187C-48A2-BF40-4E0F373B0E49
P2860
Valproic acid for the treatment of pediatric malignant glioma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Valproic acid for the treatment of pediatric malignant glioma.
@ast
Valproic acid for the treatment of pediatric malignant glioma.
@en
type
label
Valproic acid for the treatment of pediatric malignant glioma.
@ast
Valproic acid for the treatment of pediatric malignant glioma.
@en
prefLabel
Valproic acid for the treatment of pediatric malignant glioma.
@ast
Valproic acid for the treatment of pediatric malignant glioma.
@en
P2093
P356
P1433
P1476
Valproic acid for the treatment of pediatric malignant glioma.
@en
P2093
P304
P356
10.1055/S-2008-1043809
P577
1999-07-01T00:00:00Z